These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34356623)

  • 1. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer.
    Liu CL; Yuan RH; Mao TL
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.
    Fessart D; Robert J; Hartog C; Chevet E; Delom F; Babin G
    J Exp Clin Cancer Res; 2021 Aug; 40(1):271. PubMed ID: 34452625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.
    Li M; Zhang S; Ma Y; Yang Y; An R
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33846814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
    Heinze K; Rengsberger M; Gajda M; Jansen L; Osmers L; Oliveira-Ferrer L; Schmalfeldt B; Dürst M; Häfner N; Runnebaum IB
    Clin Epigenetics; 2021 Jan; 13(1):15. PubMed ID: 33482905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic biomarkers in ovarian cancer.
    Huang J; Hu W; Sood AK
    Cancer Biomark; 2010-2011; 8(4-5):231-51. PubMed ID: 22045356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
    Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
    Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer.
    Luo T; Jiang Y; Yang J
    Dis Markers; 2021; 2021():1244612. PubMed ID: 34422133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1.
    Nakae A; Kodama M; Okamoto T; Tokunaga M; Shimura H; Hashimoto K; Sawada K; Kodama T; Copeland NG; Jenkins NA; Kimura T
    Biochem Biophys Res Commun; 2021 May; 552():120-127. PubMed ID: 33744759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer.
    Frezzini S; Lonardi S
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
    Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
    Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer.
    Wang C; Wen A; Qiao J; Liu Y; Guo Y; Wang W
    Med Sci Monit; 2020 Apr; 26():e921370. PubMed ID: 32254065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Protein Biomarkers in Epithelial Ovarian Cancer Prognosis: An Aid for Multivariate Indexing.
    Paliwal P; Ranade H; Desai D; Datta M
    Curr Protein Pept Sci; 2021; 22(7):505-513. PubMed ID: 33568031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
    Krzystyniak J; Ceppi L; Dizon DS; Birrer MJ
    Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i4-i10. PubMed ID: 27141069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 19. Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer.
    Deo A; Mukherjee S; Rekhi B; Ray P
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S64-S69. PubMed ID: 32108633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
    Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
    J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.